(Q34117732)

31 July 2017

1 reference

title

Scleroderma: from pathophysiology to novel therapeutic approaches (English)

1 reference

31 July 2017

1 reference

1

Nicolas Hunzelmann

1 reference

31 July 2017

Thomas Krieg

2

1 reference

31 July 2017

publication date

1 May 2010

1 reference

31 July 2017

published in

Experimental Dermatology

1 reference

31 July 2017

volume

19

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

393-400

1 reference

High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01082.X

Pivotal role of cathepsin K in lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01082.X

Evidence that fibroblasts derive from epithelium during tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01082.X

Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01082.X

CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01082.X

10.1111/J.1600-0625.2010.01082.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference